Globe Life Inc (GL)
🔔 Watch stock
Globe Life insures lower-middle to middle-income America with life and supplemental health policies, and it shows up in our Joshua growth scanner (rank 20, as of July 17, 2026). We read the annual reports (10-K) for 2024 and 2025 and the quarterly report (10-Q) as of March 31, 2026: a profit machine with a 20.9 percent return on equity, a book value that rose 19 percent, and $685 million of share buybacks in 2025 — but also an April 2024 short-seller episode, a securities class action that survived the company's dismissal motion in September 2025, and government footnotes that vanished between two annual reports. Not investment advice — just the question of what a pristine balance sheet is worth when the fight is not about the numbers but about how they are made.
Appears in These Scanners
This stock currently matches 22 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Basics
Performance
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AI Rating
Uses AIGlobe Life Inc. (NYSE: GL) ist ein Lebens- und Krankenzusatzversicherer ohne KI-Umsätze. Der Geschäftsbericht 10-K für 2025 nennt künstliche Intelligenz ausschließlich im Kontext der eigenen IT-Modernisierung („innovative, responsible, and secure use of artificial intelligence“) sowie als allgemeines operatives IT-Risiko. Das belegt einen internen, operativen KI-Einsatz, aber kein KI-Produkt und keine KI-Umsatzquelle. Vorrangprüfung: kein Verkauf von KI; der Risk-Factor-Hinweis auf „responsible use of emerging technologies, including artificial intelligence“ ist eine allgemeine Technik-/Betriebsrisiko-Floskel ohne konkreten Bezug auf eine Bedrohung des Versicherungs-Geschäftsmodells (kein „bedroht“). Erste zutreffende Kategorie nach Vorrang ‚Verkauft > Bedroht > Nutzt > Neutral‘ ist damit ‚Nutzt KI‘.
View the full file — quotes, sources, reviewed filings
„This modernization includes the innovative, responsible, and secure use of artificial intelligence (“AI”)."
Diese Modernisierung umfasst den innovativen, verantwortungsvollen und sicheren Einsatz künstlicher Intelligenz („KI“).
„The failure to maintain effective information systems or manage responsible use of emerging technologies, including artificial intelligence, could adversely affect our financial condition and results of operations at the Company."
Das Versäumnis, wirksame Informationssysteme zu unterhalten oder den verantwortungsvollen Einsatz neuer Technologien einschließlich künstlicher Intelligenz zu steuern, könnte die Finanzlage und die Geschäftsergebnisse des Unternehmens beeinträchtigen.
Filings Reviewed: 10-K 2026-02-25 · 10-Q 2026-05-07 · 10-K 2025-02-26
Rated on July 17, 2026 · How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 3.01 | 4.60 | 1,466 | 3.60 | 17.40 | 337 | 322 |
| 2025: Q1 | 3.01 | 12.70 | 1,480 | 4.50 | 17.20 | 432 | 420 |
| 2025: Q2 | 3.05 | 10.90 | 1,481 | 2.80 | 17.10 | 308 | 295 |
| 2025: Q3 | 4.73 | 37.50 | 1,513 | 4.00 | 25.60 | 306 | 209 |
| 2025: Q4 | 3.29 | 9.30 | 1,524 | 3.90 | 17.50 | 351 | 330 |
| 2026: Q1 | 3.39 | 12.50 | 1,560 | 5.30 | 17.30 | 421 | 396 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Assessment: Opportunities & Risks
A 20.9 percent return on equity (2025), net operating income per share up 17 percent to $14.52, premium up 5 percent to $4.89 billion — the earnings curve does not bend in any of the three years, not even in 2024, the year of the short-seller episode (annual report 10-K for 2025).
Book value per share up 19 percent to $74.17 (excluding AOCI $96.16), plus $685 million of buybacks in 2025 at an average of $126.41 — management concentrates earnings per share consistently, backed by $5.97 billion of equity.
From the April 2024 short-seller episode, one securities class action and five derivative suits are pending; the company's motion to dismiss was denied on September 29, 2025, and the size of any loss cannot be reasonably estimated per the report (10-K 2025, Note 5). The dispute is about the narrative around the numbers, not the numbers themselves.
The engine is tens of thousands of independent agents whose sales practices are at the center of the allegations — a reputational and regulatory risk that is hard to quantify and steer. The 2024 report also named a DOJ subpoena and an SEC inquiry that no longer appear in the 2025 report (resolution likely, but not expressly confirmed).
At the average 2025 repurchase price of $126.41, the market pays a good 8 to 9 times operating earnings and about 1.3 times AOCI-adjusted book value — low for a 16 to 21 percent return on capital. The discount is the price of the controversy, whose outcome no filing quantifies.
Globe Life is one of the most reliable profit machines in U.S. insurance: a 20.9 percent return on equity, growing book value, $685 million of share buybacks — and an earnings curve that did not bend even in 2024, the year of the short-seller episode. But its biggest risk sits not in the balance sheet, but in trust: from the April 2024 episode a securities class action is pending that survived dismissal in September 2025, and the allegations target the sales practices of tens of thousands of independent agents. Whoever invests here buys a first-rate compounder at a controversy price — and bets that a decentralized sales apparatus comes cleanly through the litigation. Not investment advice.
- GL reached our research list via the Joshua growth scanner (rank 20, as of July 17, 2026); unlike most hits, Globe Life is no growth sprinter but a capital compounder with a high return on equity.
- Metrics such as net operating income and book value "excluding AOCI" are non-GAAP measures (defined by management). They are common and meaningful at insurers but are not a GAAP standard; net income ($1.16 billion in 2025) is the directly comparable GAAP figure.
- The valuation anchor is the average 2025 repurchase price ($126.41), deliberately dated and evergreen; daily prices are not a buy argument. Globe Life's fiscal year matches the calendar year (ends December 31). Identity verified via EDGAR (CIK 0000320335, formerly Torchmark Corporation).
About the Company
Globe Life Inc. bietet über ihre Tochtergesellschaften diverse Lebens- und ergänzende Krankenversicherungsprodukte für Familien mit niedrigem und mittlerem Einkommen in den USA an.
| CEO Insider Trades (12 Mo.) | selling own stock |
|---|---|
| Employees | 3,695 |
| Headquarters | McKinney, TX |
| Website | home.globelifeinsurance.com |
| IPO Date | 30. Dec 1987 |
| Next Earnings | 22. Jul 2026 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Frank Martin Svoboda | Co-Chairman & Co-CEO | 1962 |
| James Matthew Darden | Co-Chairman & Co-CEO | 1971 |
| Thomas Peter Kalmbach | Executive VP & CFO | 1965 |
| Robert Edward Hensley | Executive VP & Chief Investment Officer | 1968 |
| Robert Brian Mitchell J.D. | Executive VP, General Counsel & Chief Risk Officer | 1964 |
| Michael Clay Majors | Executive VP & Chief Strategy Officer | 1963 |
| M. Shane Henrie | Corporate Senior VP & Chief Accounting Officer | 1974 |
| Christopher Kyle Tyler | Executive VP & Chief Information Officer | 1974 |
| Dolores L. Skarjune | Executive VP & Chief Administrative Officer | 1966 |
| Stephen Mota | Senior Director of Investor Relations | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 20, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.